Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasliwal, R. R
Right arrow Articles by Bhatia, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasliwal, R. R
Right arrow Articles by Bhatia, A.
Related Collections
Right arrow Cardiac - pharmacology
Asian Cardiovasc Thorac Ann 2003;11:364-374
© 2003 Asia Publishing EXchange Ltd

REVIEW PAPER

Pharmacotherapy of Atrial Fibrillation

Ravi R Kasliwal, MD, Mukesh Singh, MD, Gagan Manohar, MD, Naveen Aggarwal, MD, Atul Bhatia, MD

Department of Cardiology, Escorts Heart Institute and Research Centre, New Delhi, India

For reprint information contact: Ravi R Kasliwal, MD Tel: 91 11 2682 5000 Fax: 91 11 2682 5013 email: rrkasliwal{at}hotmail.com Department of Cardiology, Escorts Heart Institute and Research Centre, Okhla Road, New Delhi 110 025, India.

Atrial fibrillation is the most common sustained arrhythmia of clinical significance. Its prevalence rises with age. It is a significant cause of thromboembolic phenomena. We describe briefly the etiology and classification of atrial fibrillation, the risk factors for thromboembolism and stroke associated with it, the indications for hospitalization, and the therapeutic goal. We discuss in depth the management strategies for such patients and compare the impact of rate versus rhythm control in reducing morbidity and mortality attributed to arrhythmia, in light of past and present trials. A brief overview of the drugs used in the management of atrial fibrillation, their pharmacology and dosage, their effects and use in rhythm versus rate control with important side effects are also included. Finally, the prevention and treatment of thromboembolism in patients with atrial fibrillation, an important aspect of therapy, is revisited in light of recent advances.




This article has been cited by other articles:


Home page
 PsychosomaticsHome page
S. J. Finch and L. T. van Zyl
Cardioversion of Persistent Atrial Arrhythmia After Treatment With Venlafaxine in Successful Management of Major Depression and Posttraumatic Stress Disorder
Psychosomatics, December 1, 2006; 47(6): 533 - 536.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by the Asia Publishing EXchange Ltd.